Form 4: InfuSystem Holdings Executive VP and CFO, Barry G. Steele, Reports Transactions in Company Stock

Barry G. Steele, Executive VP and CFO of InfuSystem Holdings, Inc., reports the acquisition and disposal of company stock and derivative securities.

Summary

• On May 20, 2025, Barry G. Steele, the Executive VP and CFO of InfuSystem Holdings, Inc., filed a Form 4 with the SEC.
• The report details transactions involving InfuSystem Holdings, Inc. common stock and derivative securities.
• On May 17, 2025, Steele acquired 13,636 shares of common stock and disposed of 5,946 shares to cover tax liabilities.
• As of May 17, 2025, Steele directly owns 84,577 shares of InfuSystem Holdings, Inc. common stock.
• Steele also reports holding options to purchase 53,518 shares of common stock, which vest in equal annual installments beginning May 16, 2026.
• Additionally, Steele holds 22,531 restricted stock units (RSUs) that convert into common stock on a one-for-one basis, vesting in equal annual installments beginning May 16, 2026.
• 13,636 restricted stock units cliff vested on May 17, 2025.

Sentiment

Score: 5

Explanation: This is a neutral report of stock transactions, with no inherent positive or negative sentiment. It's a routine regulatory filing.

Future Outlook

The document does not contain explicit forward-looking statements, but it outlines the vesting schedules for stock options and restricted stock units, indicating future equity compensation for the reporting person.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.

Comparison to Industry Standards

• Equity compensation practices, such as stock options and restricted stock units, are standard across publicly traded companies to align management's interests with those of shareholders.
• Vesting schedules, like the annual installments described, are typical for these types of equity grants.
• The amounts and terms of the grants would need to be compared to similar companies in the healthcare or medical device industry to assess their competitiveness.

Stakeholder Impact

• The transactions reported may have a minor impact on shareholders, as they reflect changes in insider ownership.
• The vesting of stock options and RSUs incentivizes the executive to contribute to the company's success.

Key Dates

Keywords

Form 4, InfuSystem Holdings, Barry G. Steele, Stock Options, Restricted Stock Units, Common Stock, Executive VP, CFO, Securities